Market Tracker

07/06 6:01pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

During the Trading Day
226.30 -2.19 / -0.96%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
227.50 +1.20 / +0.53%
 
Volume: 13.2K

Today’s Trading

Previous close228.49
Today’s open226.43
Day’s range224.46 - 229.11
Volume1,677,281
Average volume (3 months)1,717,576
Market cap$78.0B
Dividend yield--
Data as of 4:01pm ET, 07/06/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+33.21%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+43.22%
P/E ratio84.6
Price/Sales5.93
Price/Book14.38

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.33+0.67%
AZNAstraZeneca-0.29-0.44%
CELGCelgene-0.70-0.59%
LLYEli Lilly and Co+0.21+0.24%
Data as of 4:14pm ET, 07/06/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$2.46
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer &
Executive Vice President
Robert L. Rosiello
Corporate headquarters
Laval, Quebec

Forecasts